Sign in
4/A

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-019666

Chief Scientific Officer gave up 565 shares (to pay taxes)

  • Chief Scientific Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rodino-Klapac Louise · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-28 Shares withheld for taxes : show line 1 in the form −565 $86.97 $49,138 6,604 D
2021-03-03 Grant or award : show line 2 in the form +15,000 21,780 D
Loading xslF345X03/doc4a.xml…